|Articles|September 1, 2003
Let's Resist Biologics 'Warfare'
The advent of biologic therapies is providing dermatologists with a wholenew arsenal of medications to treat people with moderate to severe psoriasis.For the first time in many years, dermatologists have a unique opportunityto provide, perhaps, better care to our psoriasis patients.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
3
Top 5 Articles of the Week: December 7-12
4
Transformative Advances This Year and Beyond
5














